Tuberculosis Overview and Definition

Infectious Diseases: Diagnosis, Treatment & Travel Medicine

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Tuberculosis Overview and Definition

Overview and Definition of Tuberculosis

Tuberculosis (TB) is a contagious infectious disease caused by the bacterium Mycobacterium tuberculosis. It most commonly affects the lungs but can also spread to other organs such as the kidneys, brain, and spine. TB is transmitted through airborne droplets released when an infected person coughs, sneezes, speaks, or sings.

TB exists in two forms: latent tuberculosis infection (LTBI) and active tuberculosis disease. In latent TB, the bacteria remain inactive in the body without causing symptoms and are not contagious. In active TB, the bacteria multiply and cause clinical symptoms, making the patient infectious and requiring immediate medical treatment.

TB remains a major global health concern, especially in densely populated areas, regions with limited healthcare access, malnutrition, HIV infection, and weakened immune systems. Early diagnosis and appropriate treatment are essential for controlling disease spread and preventing complications.

Symptoms and Transmission of Tuberculosis

The most common symptom of active pulmonary tuberculosis is a persistent cough lasting more than 2–3 weeks. This may be accompanied by sputum production, chest pain, coughing up blood (hemoptysis), fatigue, fever, night sweats, and unexplained weight loss. Symptoms typically develop gradually, which may delay diagnosis.

Tuberculosis is transmitted through the airborne route. When a person with active pulmonary TB coughs or sneezes, microscopic droplets containing bacteria are released into the air. These particles can remain suspended in poorly ventilated environments and be inhaled by others, leading to infection.

Latent TB is not contagious; however, it can progress to active disease if the immune system weakens. Individuals at higher risk include close contacts of TB patients, healthcare workers, and people with chronic illnesses or immunosuppressive conditions.

Diagnosis and Evaluation of Tuberculosis

Tuberculosis diagnosis is based on a combination of clinical evaluation, imaging studies, and laboratory tests. A chest X-ray is often the first imaging method used and may show lung infiltrates, nodules, or cavitary lesions suggestive of TB infection.

Microbiological confirmation is achieved through sputum analysis, culture testing, and molecular diagnostics such as the GeneXpert MTB/RIF assay, which can rapidly detect Mycobacterium tuberculosis and identify rifampicin resistance.

For latent TB infection, the Tuberculin Skin Test (TST) and Interferon-Gamma Release Assays (IGRAs) are commonly used. These tests detect immune response to TB bacteria but do not distinguish between active and latent disease, making clinical correlation essential.

Treatment and Management of Tuberculosis

Tuberculosis treatment requires long-term antibiotic therapy, typically lasting at least 6 months for drug-sensitive TB. The standard regimen includes isoniazid, rifampicin, pyrazinamide, and ethambutol, administered in two phases: an intensive phase followed by a continuation phase.

Strict adherence to medication is essential to ensure successful treatment outcomes and prevent drug resistance. Incomplete or irregular treatment may lead to multidrug-resistant TB (MDR-TB) or extensively drug-resistant TB (XDR-TB), which require longer and more complex treatment regimens.

Regular follow-up, clinical monitoring, and laboratory testing are necessary throughout the treatment process to assess response and manage potential side effects.

Prevention and Control of Tuberculosis

The BCG vaccine provides partial protection against severe forms of tuberculosis, particularly in children. However, it does not fully prevent pulmonary TB in adults, making additional preventive strategies essential.

Early detection and treatment of active TB cases are the most effective methods of reducing transmission. Contact tracing, screening of high-risk populations, and preventive therapy for latent TB infection play a crucial role in disease control.

Public health measures such as proper ventilation, reduced overcrowding, infection control in healthcare settings, and increased awareness significantly reduce transmission risk. WHO-endorsed programs such as DOTS (Directly Observed Treatment, Short-course) support treatment adherence and global TB control efforts.

Tuberculosis Care at Liv Hospital

Comprehensive tuberculosis management requires a multidisciplinary and patient-centered approach. Liv Hospital offers advanced diagnostic technologies, including molecular testing, high-resolution imaging, and expert clinical evaluation for TB patients.

Treatment plans are individualized based on drug susceptibility testing and international WHO guidelines. Liv Hospital’s infectious disease and pulmonology teams work together to ensure accurate diagnosis, effective treatment, and continuous follow-up care.

For international patients, Liv Hospital provides integrated support services including interpreter assistance, isolation facilities with negative-pressure rooms, and coordinated treatment planning, ensuring a safe and efficient healthcare experience.